PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.29%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
1.14%
Positive gross profit growth while 1097.HK is negative. John Neff would see a clear operational edge over the competitor.
27.53%
Positive EBIT growth while 1097.HK is negative. John Neff might see a substantial edge in operational management.
1410.11%
Positive operating income growth while 1097.HK is negative. John Neff might view this as a competitive edge in operations.
28.96%
Positive net income growth while 1097.HK is negative. John Neff might see a big relative performance advantage.
22.70%
Positive EPS growth while 1097.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
32.10%
Positive diluted EPS growth while 1097.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.48%
Share change of 0.48% while 1097.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-2.63%
Reduced diluted shares while 1097.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-80.68%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-108.88%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
1876.81%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
246.02%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
154.61%
5Y OCF/share CAGR above 1.5x 1097.HK's 24.79%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
138.03%
3Y OCF/share CAGR above 1.5x 1097.HK's 74.28%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
167.32%
5Y net income/share CAGR above 1.5x 1097.HK's 63.35%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
160.68%
3Y net income/share CAGR above 1.5x 1097.HK's 39.89%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-7.82%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
15.12%
Positive short-term equity growth while 1097.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.84%
We show growth while 1097.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.66%
Asset growth at 75-90% of 1097.HK's 3.45%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
5.21%
Positive BV/share change while 1097.HK is negative. John Neff sees a clear edge over a competitor losing equity.
25.60%
Debt growth far above 1097.HK's 15.46%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-9.84%
We cut SG&A while 1097.HK invests at 0.78%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.